Bausch Health Companies Inc. (BHC) Social Stream
BAUSCH HEALTH COMPANIES INC (BHC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BAUSCH HEALTH COMPANIES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-14 | 8 | $55 | $27 | $38.444 | $6.59 | 483.37% |
| 2022-01-13 | 6 | $55 | $31 | $40.142 | $6.59 | 509.14% |
| 2022-01-20 | 5 | $55 | $31 | $40.142 | $6.59 | 509.14% |
| 2022-02-09 | 5 | $55 | $27.001 | $38.5 | $6.59 | 484.22% |
| 2022-05-11 | 6 | $55 | $25 | $37.5 | $6.59 | 469.04% |
| 2022-06-08 | 6 | $55 | $7 | $31.333 | $6.59 | 375.46% |
| 2022-06-13 | 7 | $55 | $7 | $29.4 | $6.59 | 346.13% |
| 2022-07-26 | 7 | $40 | $7 | $21.5 | $6.59 | 226.25% |
| 2022-07-28 | 7 | $40 | $7 | $19.428 | $6.59 | 194.81% |
| 2022-07-29 | 6 | $40 | $5 | $18.666 | $6.59 | 183.25% |
| 2022-08-10 | 7 | $40 | $5 | $18.666 | $6.59 | 183.25% |
| 2022-08-24 | 7 | $40 | $4.5 | $13.25 | $6.59 | 101.06% |
| 2022-09-01 | 7 | $40 | $5 | $13.833 | $6.59 | 109.91% |
The Trend in the Analyst Price Target
BHC's average price target has moved down $12.7 over the prior 22 months.
Over the past 43 weeks, BHC's average upside potential has been 153.47%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-14 | 8 | 55 | 27 | 38.444 | 26.44 | 45.4% |
| 2021-12-14 | 8 | 55 | 27 | 38.500 | 24.49 | 57.21% |
| 2022-01-20 | 6 | 55 | 31 | 40.142 | 24.92 | 61.08% |
| 2022-07-29 | 6 | 40 | 5 | 18.666 | 4.62 | 304.03% |
| 2022-08-10 | 7 | 40 | 5 | 18.666 | 5.65 | 230.37% |
BHC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.57 | 2 | 0 | 4 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 29 months, BHC's average broker recommendation rating worsened by 0.79.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BHC as an investment opportunity.
- In the context of all US stocks, BAUSCH HEALTH COMPANIES INC's variance in analysts' estimates is lower than -1678.93% of them.
- In terms of how BAUSCH HEALTH COMPANIES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1768.51% of that group.
- In the context of stocks in the large market cap category, BAUSCH HEALTH COMPANIES INC's number of analysts covering the stock is higher than 247.19% of them.
- BAUSCH HEALTH COMPANIES INC's average analyst price target is higher than 304.83% of stocks in the large market cap category.
Stocks similar to BAUSCH HEALTH COMPANIES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BGNE, ALNY, and ALKS.
View All Top Stocks by Price Target
Make investment decisions regarding BHC using the data that counts. Try POWR Ratings for free.